Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: Formation of circulating autoantibody against 190-kDa antigen

Acta Dermato-Venereologica

Volumn 86, Issue 3, 2006, Pages 241-244

  Yun, Sook Jung ^a   Lee, Jee Bum ^a   Kim, Eun Jung ^a   Quan, Gen ^a   Kim, Seong Jin ^a   Won, Young Ho ^a   Lee, Seung Chul ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Auto antibody; Carbamazepine; DRESS; Valproate

Indexed keywords

ANTIHISTAMINIC AGENT; AUTOANTIBODY; CARBAMAZEPINE; PREDNISOLONE; VALPROIC ACID;

ADULT; ANAMNESIS; ANTIBODY BLOOD LEVEL; ARTICLE; BLISTER; CASE REPORT; CLINICAL FEATURE; CROSS ALLERGY; DRUG ERUPTION; DRUG TOLERABILITY; EOSINOPHILIA; EPILEPSY; ERYTHEMA; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; SKIN PRURITUS; SYMPTOMATOLOGY;

ADULT; ANTICONVULSANTS; AUTOANTIBODIES; CARBAMAZEPINE; CROSS REACTIONS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; EOSINOPHILIA; FEMALE; HUMANS; VALPROIC ACID;

EID: 33745010466     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0049     Document Type: Article

References (25)

1. Chaiken BH, Goldberg BI, Segal JP. Dilantin hypersensitivity: report of a case of hepatitis with jaundice, pyrexia, and exfoliative dermatitis. N Engl J Med 1950; 242: 897-898.
2. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003; 206: 353-356.
3. Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome. Incidence, prevention and management. Drug Saf 1999; 21: 489-501.
4. Arevalo-Lorido JC, Carretero-Gomez J, Bureo-Dacal JC, Montero-Leal C, Bureo-Dacal P. Antiepileptic drug hypersensitivity syndrome in a patient treated with valproate. Br J Clin Pharmacol 2003; 55: 413-416.
5. Cogrel O, Beylot-Barry M, Vergier B, Dubus P, Doutre MS, Merlio JP, Beylot C. Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with cabamazepine. Br J Dermatol 2001; 144: 1235-1238.
6. Klassen BD, Sadler RM. Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second anti-epileptic drug. Epilepsia 2001; 42: 433-435.
7. Allam JP, Paus T, Reichel C, Bieber T, Novak N. DRESS syndrome associated with carbamazepine and phenytoin. Eur J Dermatol 2004; 14: 339-342.
8. Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998; 39: S3-S7.
9. Colletti RB, Trainer TD, Krawisz BR. Reversible valproate fulminant hepatic failure. J Pediatr Gastroenterol Nutr 1986; 5: 990-994.
10. Picart N, Periole B, Mazereeuw J, Bonafe JL. Drug hypersensitivity syndrome due to valproic acid. Presse Med 2000; 29: 648-650.
11. Plantin P, Cartier H, Le Bihan G, Clouard P, Lellouche F, Leroy JP. Drug hypersensitivity syndrome during treatment with valproic acid. Presse Med 1995; 24: 1624.
12. Huang YL, Hong HS, Wang ZW, Kuo TT. Fatal sodium valproate-induced hypersensitivity syndrome with lichenoid dermatitis and fulminant hepatitis. J Am Acad Dermatol 2003; 49: 316-319.
13. Canilleau V, Dompmartin A, Verneuil L, Michel M, Leroy D. Hypersensitivity syndrome due to 2 anticonvulsant drugs. Contact Dermatitis 1999; 41: 141-144.
14. Li LM, Russo M, O'Donhoghue MF, Duncan JS, Sander JWAS. Allergic skin rash with lamotrigine and concomitant valproate therapy. Arq Neuropsiquiatr 1996; 54: 47-49.
15. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988; 82: 1826-1832.
16. Hyson C, Sadler M. Cross sensitivity of skin rashes with antiepileptic drugs. Can J Neurol Sci 1997; 24: 245-249.
17. Gleichmann H. Studies on the mechanism of drug sensitization: T-cell dependent popliteal lymph node reaction to diphenylhydantoin. Clin Immunol Immunopathol 1981; 18: 203-211.
18. Leeder JS, Riley RJ, Cook VA, Spielberg SP. Human anticytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. J Pharmacol Exp Ther 1992; 263: 360-367.
19. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Descamps D, Saraux JL. Human herpes virus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997; 137: 605-608.
20. Kano Y, Inoaka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpes-virus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004; 140: 183-188.
21. Scheuerman O, Nofech-Moses Y, Rachmel A, Ashkenazi S. Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin. Pediatrics 2001; 107: 14-15.
22. Yoshimura T, Seishima M, Nakashima K, Yasuhara Y, Adachi S, Kawaguchi M. Increased antibody levels to desmogleins 1 and 3 after administration of carbamazepine. Clin Exp Dermatol 2001; 26: 441-445.
23. Patterson CR, Davies MG. Carbamazepine-induced pemphigus. Clin Exp Dermatol 2003; 28: 98-99.
24. Ghohestani R, Joly P, Gilbert D, Nicolas JF, Thomine E, Cozzani E. Autoantibody formation against a 190-kDa antigen of the desmosomal plaque in pemphigus foliaceus. Br J Dermatol 1997; 137: 774-779.
25. Kiyokawa C. Envoplakin and periplakin are the paraneoplastic pemphigus antigens. Kurume Med J 1999; 46: 71-78.